BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ong JJ, Baggaley RC, Wi TE, Tucker JD, Fu H, Smith MK, Rafael S, Anglade V, Falconer J, Ofori-Asenso R, Terris-Prestholt F, Hodges-Mameletzis I, Mayaud P. Global Epidemiologic Characteristics of Sexually Transmitted Infections Among Individuals Using Preexposure Prophylaxis for the Prevention of HIV Infection: A Systematic Review and Meta-analysis. JAMA Netw Open 2019;2:e1917134. [PMID: 31825501 DOI: 10.1001/jamanetworkopen.2019.17134] [Cited by in Crossref: 34] [Cited by in F6Publishing: 50] [Article Influence: 11.3] [Reference Citation Analysis]
Number Citing Articles
1 Schmidt D, Kollan C, Bartmeyer B, Bremer V, Schikowski T, Friebe M, Schellberg S, Scholten S, Bickel M, Hanhoff N, Rüsenberg R, Schewe K; NEPOS study group. Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany. Infection 2022. [PMID: 36168098 DOI: 10.1007/s15010-022-01919-3] [Reference Citation Analysis]
2 Papageorgiou V, Crittendon E, Coukan F, Davies B, Ward H. Impact of daily, oral pre-exposure prophylaxis on the risk of bacterial sexually transmitted infections among cisgender women: a systematic review and narrative synthesis. Wellcome Open Res 2022;7:108. [DOI: 10.12688/wellcomeopenres.17457.2] [Reference Citation Analysis]
3 Pham MD, Ong JJ, Anderson DA, Drummer HE, Stoové M. Point-of-Care Diagnostics for Diagnosis of Active Syphilis Infection: Needs, Challenges and the Way Forward. IJERPH 2022;19:8172. [DOI: 10.3390/ijerph19138172] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Celum CL, Bukusi EA, Bekker LG, Delany-Moretlwe S, Kidoguchi L, Omollo V, Rousseau E, Travill D, Morton JF, Mogaka F, O'Malley G, Barnabee G, van der Straten A, Donnell D, Parikh UM, Kudrick L, Anderson PL, Haberer JE, Wu L, Heffron R, Johnson R, Morrison S, Baeten JM; POWER Study Team. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project. J Int AIDS Soc 2022;25:e25962. [PMID: 35822945 DOI: 10.1002/jia2.25962] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Traeger MW, Murphy D, Ryan KE, Asselin J, Cornelisse VJ, Wilkinson AL, Hellard ME, Wright EJ, Stoové MA. Latent Class Analysis of Sexual Behaviours and Attitudes to Sexually Transmitted Infections Among Gay and Bisexual Men Using PrEP. AIDS Behav 2022;26:1808-20. [PMID: 34782934 DOI: 10.1007/s10461-021-03529-w] [Reference Citation Analysis]
6 Coyer L, Prins M, Davidovich U, van Bilsen WPH, Schim van der Loeff MF, Hoornenborg E, Matser A, Boyd A. Trends in Sexual Behavior and Sexually Transmitted Infections After Initiating Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Men Who Have Sex with Men from Amsterdam, the Netherlands: A Longitudinal Exposure-Matched Study. AIDS Patient Care STDS 2022;36:208-18. [PMID: 35687814 DOI: 10.1089/apc.2021.0219] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Bradshaw D, Taylor GP. HTLV-1 Transmission and HIV Pre-exposure Prophylaxis: A Scoping Review. Front Med 2022;9:881547. [DOI: 10.3389/fmed.2022.881547] [Reference Citation Analysis]
8 Martel-Laferrière V, Feaster DJ, Metsch LR, Shackman BR, Loignon C, Nosyk B, Tookes H, Behrends CN, Arruda N, Adigun O, Goyer ME, Kolber MA, Mary JF, Rodriguez AE, Yanez IG, Pan Y, Khemiri R, Gooden L, Sako A, Bruneau J. M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID. Trials 2022;23:341. [PMID: 35461260 DOI: 10.1186/s13063-022-06085-3] [Reference Citation Analysis]
9 Streeck H, Jansen K, Crowell TA, Esber A, Jessen HK, Cordes C, Scholten S, Schneeweiss S, Brockmeyer N, Spinner CD, Bickel M, Esser S, Hartikainen J, Stoehr A, Lehmann C, Marcus U, Vehreschild JJ, Knorr A, Brillen AL, Tiemann C, Robb ML, Michael NL. HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019. Euro Surveill 2022;27. [PMID: 35393933 DOI: 10.2807/1560-7917.ES.2022.27.14.2100591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Songtaweesin WN, Pornpaisalsakul K, Kawichai S, Wacharachaisurapol N, Wongharn P, Yodkitudomying C, Panichnantakul P, Theerawit T, Pankam T, Puthanakit T. Sexually transmitted infections incidence in young Thai men who have sex with men and transgender women using HIV pre-exposure prophylaxis. Int J STD AIDS 2022;33:447-55. [PMID: 35282719 DOI: 10.1177/09564624211056749] [Reference Citation Analysis]
11 Papageorgiou V, Crittendon E, Coukan F, Davies B, Ward H. Impact of daily, oral pre-exposure prophylaxis on the risk of bacterial sexually transmitted infections among cisgender women: a systematic review and narrative synthesis. Wellcome Open Res 2022;7:108. [DOI: 10.12688/wellcomeopenres.17457.1] [Reference Citation Analysis]
12 Saxton PJW, Azariah S, Cavadino A, Forster RF, Jenkins R, Werder SF, Southey K, Rich JG. Adherence, Sexual Behavior and Sexually Transmitted Infections in a New Zealand Prospective PrEP Cohort: 12 Months Follow-up and Ethnic Disparities. AIDS Behav 2022. [PMID: 35167038 DOI: 10.1007/s10461-022-03617-5] [Reference Citation Analysis]
13 De Baetselier I, Vuylsteke B, Reyniers T, Smet H, Van den Bossche D, Kenyon C, Crucitti T. Worryingly high prevalence of resistance-associated mutations to macrolides and fluoroquinolones in Mycoplasma genitalium among men who have sex with men with recurrent sexually transmitted infections. Int J STD AIDS. [DOI: 10.1177/09564624211070704] [Reference Citation Analysis]
14 Wray TB, Chan PA, Guigayoma JP, Kahler CW. Game Plan-a Brief Web-Based Intervention to Improve Uptake and Use of HIV Pre-exposure Prophylaxis (PrEP) and Reduce Alcohol Use Among Gay and Bisexual Men: Content Analysis. JMIR Form Res 2022;6:e30408. [PMID: 34989679 DOI: 10.2196/30408] [Reference Citation Analysis]
15 Fiore JR, Sica S, Di Stefano M. To Run with the Hares and Hunt with the Hounds: How to get HIV Transmission Reduced in MSM Using PrEP without Increasing STI Incidence? TOAIDJ 2021;15:81-3. [DOI: 10.2174/1874613602115010081] [Reference Citation Analysis]
16 Apers L, Vanhamel J, Caluwaerts S, Platteau T, Kenyon C, Florence E. Impact of PrEP on a STI clinic in a Belgian context: a provider's perspective. Acta Clin Belg 2021;76:477-81. [PMID: 32468957 DOI: 10.1080/17843286.2020.1767995] [Reference Citation Analysis]
17 Aboud L, Xu Y, Chow EPF, Wi T, Baggaley R, Mello MB, Fairley CK, Ong JJ. Diagnostic accuracy of pooling urine, anorectal, and oropharyngeal specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae: a systematic review and meta-analysis. BMC Med 2021;19:285. [PMID: 34819068 DOI: 10.1186/s12916-021-02160-9] [Reference Citation Analysis]
18 Moreira JS, Vasconcelos R, Doi AM, Avelino-Silva VI. Real-life occurrence of bacterial sexually transmitted infections among PrEP users: improving the diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae with multisite screening. Rev Inst Med Trop Sao Paulo 2021;63:e76. [PMID: 34755815 DOI: 10.1590/S1678-9946202163076] [Reference Citation Analysis]
19 Stewart J, Baeten JM. HIV pre-exposure prophylaxis and sexually transmitted infections: intersection and opportunity. Nat Rev Urol 2021. [PMID: 34697493 DOI: 10.1038/s41585-021-00527-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Chow EPF, Lee D, Bond S, Fairley CK, Maddaford K, Wigan R, Fehler G, Lange SA, De Petra V, Bissessor M, Bradshaw CS, Howden BP, Hocking JS, Williamson DA, Chen MY. Nonclassical Pathogens as Causative Agents of Proctitis in Men who Have Sex With Men. Open Forum Infect Dis 2021;8:ofab137. [PMID: 34671693 DOI: 10.1093/ofid/ofab137] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70:1-187. [PMID: 34292926 DOI: 10.15585/mmwr.rr7004a1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 124] [Article Influence: 1.0] [Reference Citation Analysis]
22 O'Byrne P, Orser L, Vandyk A. Immediate PrEP after PEP: Results from an Observational Nurse-Led PEP2PrEP Study. J Int Assoc Provid AIDS Care 2020;19:2325958220939763. [PMID: 32856549 DOI: 10.1177/2325958220939763] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
23 Xu X, Bradshaw CS, Chow EPF, Ong JJ, Hocking JS, Fairley CK, Zhang L. Modelling the multiple anatomical site transmission of Mycoplasma genitalium among men who have sex with men in Australia. Sci Rep 2021;11:11087. [PMID: 34045569 DOI: 10.1038/s41598-021-90627-3] [Reference Citation Analysis]
24 Nguyen LH, Nguyen HLT, Tran BX, Larsson M, Rocha LEC, Thorson A, Strömdahl S. A qualitative assessment in acceptability and barriers to use pre-exposure prophylaxis (PrEP) among men who have sex with men: implications for service delivery in Vietnam. BMC Infect Dis 2021;21:472. [PMID: 34030652 DOI: 10.1186/s12879-021-06178-5] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
25 Bhatia R, Le Minh G, An LT, Thai TT, Bui H, Ngoc LB, Vu D, Abdul-Quader A. Substantial Need for Preexposure Prophylaxis Among Men Who Have Sex With Men in Hanoi, Vietnam. Sex Transm Dis 2021;48:e56-8. [PMID: 32890336 DOI: 10.1097/OLQ.0000000000001270] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Nadarzynski T, Frost M, Miller D, Wheldon CW, Wiernik BM, Zou H, Richardson D, Marlow LAV, Smith H, Jones CJ, Llewellyn C. Vaccine acceptability, uptake and completion amongst men who have sex with men: A systematic review, meta-analysis and theoretical framework. Vaccine 2021;39:3565-81. [PMID: 34034949 DOI: 10.1016/j.vaccine.2021.05.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
27 Pečavar B, Kokošar Ulčar B, Kordiš M, Pleško M, Turel G, Vovko T, Tomažič J. Pre-exposure prophylaxis for HIV with oral tenofovir disoproxil fumarate/emtricitabine in men who have sex with men: Slovenian national demonstration project. Int J STD AIDS 2021;:9564624211019876. [PMID: 34006161 DOI: 10.1177/09564624211019876] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Alfaiate D, Giaché S, Pradat P, Cotte L, Chidiac C; Croix-Rousse STI Study Group. Sexually transmitted infections knowledge in different populations attending a French University Hospital - A prospective observational study. Epidemiol Infect 2021;:1-18. [PMID: 33880990 DOI: 10.1017/S0950268821000881] [Reference Citation Analysis]
29 Wanga V, Peebles K, Obiero A, Mogaka F, Omollo V, Odoyo JB, Morton JF, Bukusi EA, Celum C, Baeten JM, Barnabas RV. Cost of pre-exposure prophylaxis delivery in family planning clinics to prevent HIV acquisition among adolescent girls and young women in Kisumu, Kenya. PLoS One 2021;16:e0249625. [PMID: 33857195 DOI: 10.1371/journal.pone.0249625] [Reference Citation Analysis]
30 Thivalapill N, Jasumback CL, Perry SH, Dlamini L, Matsenjwa M, Masangane ZT, Mavimbela M, Mthethwa N, Kirchner HL, Mphaya J, Lukhele B, Mandalakas A, Kay AW. Predicting Sexually Transmitted Infections Among HIV+ Adolescents and Young Adults: A Novel Risk Score to Augment Syndromic Management in Eswatini. J Acquir Immune Defic Syndr 2020;85:543-52. [PMID: 32947446 DOI: 10.1097/QAI.0000000000002512] [Reference Citation Analysis]
31 Ung MJ, Fairley CK, Martin SJ, Ong JJ. Pre-exposure Prophylaxis for HIV-An Opportunity for the Global Control of Sexually Transmitted Infections. J Acquir Immune Defic Syndr 2021;86:e116-7. [PMID: 33252545 DOI: 10.1097/QAI.0000000000002582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Tan RKJ, Wang Y, Prem K, Harrison-Quintana J, Teo AKJ, Kaur N, Cook AR, Chen MI, Wong CS. HIV Pre-Exposure Prophylaxis, Condoms, or Both? Insights on Risk Compensation Through a Discrete Choice Experiment and Latent Class Analysis Among Men Who Have Sex With Men. Value Health 2021;24:714-23. [PMID: 33933241 DOI: 10.1016/j.jval.2020.11.023] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Saeed S, Goldman M, Uzicanin S, O'Brien SF. Evaluation of a pre-exposure prophylaxis (PrEP)/post-exposure prophylaxis (PEP) deferral policy among blood donors. Transfusion 2021;61:1684-9. [PMID: 33724472 DOI: 10.1111/trf.16349] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
34 Ong JJ, Fu H, Baggaley RC, Wi TE, Tucker JD, Smith MK, Rafael S, Falconer J, Terris-Prestholt F, Mameletzis I, Mayaud P. Missed opportunities for sexually transmitted infections testing for HIV pre-exposure prophylaxis users: a systematic review. J Int AIDS Soc 2021;24:e25673. [PMID: 33605081 DOI: 10.1002/jia2.25673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
35 Lorenc A, Nicholls J, Kesten JM, Macgregor L, Speare N, Harryman L, Turner KME, Horner P, Horwood J. Human Immunodeficiency Virus Preexposure Prophylaxis Knowledge, Attitudes and Perceptions of Sexual Health Risk in an Age of Sexually Transmitted Infection Antimicrobial Resistance. Sex Transm Dis 2021;48:685-92. [PMID: 33534406 DOI: 10.1097/OLQ.0000000000001384] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Stelzle D, Godfrey-Faussett P, Jia C, Amiesimaka O, Mahy M, Castor D, Hodges-Mameletzis I, Chitembo L, Baggaley R, Dalal S. Estimating HIV pre-exposure prophylaxis need and impact in Malawi, Mozambique and Zambia: A geospatial and risk-based analysis. PLoS Med 2021;18:e1003482. [PMID: 33428611 DOI: 10.1371/journal.pmed.1003482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Quaife M, Terris-Prestholt F, Mukandavire Z, Vickerman P. Modelling the effect of market forces on the impact of introducing human immunodeficiency virus pre-exposure prophylaxis among female sex workers. Health Econ 2021;30:659-79. [PMID: 33377250 DOI: 10.1002/hec.4211] [Reference Citation Analysis]
38 Ambrosioni J, Petit E, Liegeon G, Laguno M, Miró JM. Primary HIV-1 infection in users of pre-exposure prophylaxis. Lancet HIV 2021;8:e166-74. [PMID: 33316212 DOI: 10.1016/S2352-3018(20)30271-X] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
39 McManus H, Grulich AE, Amin J, Selvey C, Vickers T, Bavinton B, Zablotska I, Vaccher S, Jin F, Holden J, Price K, Yeung B, Cabrera Quichua G, Ogilvie E, McNulty A, Smith D, Guy R. Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men. JAMA Netw Open 2020;3:e2030806. [PMID: 33355675 DOI: 10.1001/jamanetworkopen.2020.30806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
40 Chow EPF, Vodstrcil LA, Williamson DA, Maddaford K, Hocking JS, Ashcroft M, De Petra V, Bradshaw CS, Fairley CK. Incidence and duration of incident oropharyngeal gonorrhoea and chlamydia infections among men who have sex with men: prospective cohort study. Sex Transm Infect 2021;97:452-7. [DOI: 10.1136/sextrans-2020-054764] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
41 Jin F, Dore GJ, Matthews G, Luhmann N, Macdonald V, Bajis S, Baggaley R, Mathers B, Verster A, Grulich AE. Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2021;6:39-56. [PMID: 33217341 DOI: 10.1016/S2468-1253(20)30303-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
42 O'halloran C, Croxford S, Mohammed H, Gill ON, Hughes G, Fifer H, Allen H, Owen G, Nutland W, Delpech V, Saunders JM. Factors associated with reporting antibiotic use as STI prophylaxis among HIV PrEP users: findings from a cross-sectional online community survey, May–July 2019, UK. Sex Transm Infect 2021;97:429-33. [DOI: 10.1136/sextrans-2020-054592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
43 Stankevitz K, Grant H, Lloyd J, Gomez GB, Kripke K, Torjesen K, Ong JJ, Terris-Prestholt F. Oral preexposure prophylaxis continuation, measurement and reporting. AIDS 2020;34:1801-11. [PMID: 32558660 DOI: 10.1097/QAD.0000000000002598] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
44 Spornraft-Ragaller P. [Rapid testing for sexually transmitted infections]. MMW Fortschr Med 2020;162:44-8. [PMID: 32583248 DOI: 10.1007/s15006-020-0646-x] [Reference Citation Analysis]
45 Rutstein SE, Smith DK, Dalal S, Baggaley RC, Cohen MS. Initiation, discontinuation, and restarting HIV pre-exposure prophylaxis: ongoing implementation strategies. Lancet HIV 2020;7:e721-30. [PMID: 32861269 DOI: 10.1016/S2352-3018(20)30203-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
46 Allen H, Pitt R, Bardsley M, Smolarchuk C, Sullivan A, Mohammed H, Cole M, Fifer H, Wallace L, Thomas D, Irvine N, Templeton K, Hughes G, Simms I. Investigating the decline in Lymphogranuloma venereum diagnoses in men who have sex with men in the United Kingdom since 2016: an analysis of surveillance data. Sex Health 2020;17:344-51. [PMID: 32762828 DOI: 10.1071/SH20001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
47 Chandra C, Weiss KM, Kelley CF, Marcus JL, Jenness SM. Gaps in Sexually Transmitted Infection Screening among Men who Have Sex with Men in PrEP Care in the United States. Clin Infect Dis 2020:ciaa1033. [PMID: 32702116 DOI: 10.1093/cid/ciaa1033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
48 Viswasam N, Schwartz S, Baral S. Characterizing the role of intersecting stigmas and sustained inequities in driving HIV syndemics across low-to-middle-income settings. Curr Opin HIV AIDS 2020;15:243-9. [PMID: 32487815 DOI: 10.1097/COH.0000000000000630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Mayer KH, Agwu A, Malebranche D. Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review. Adv Ther 2020;37:1778-811. [PMID: 32232664 DOI: 10.1007/s12325-020-01295-0] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 30.5] [Reference Citation Analysis]
50 Celum C, Baeten J. PrEP for HIV Prevention: Evidence, Global Scale-up, and Emerging Options. Cell Host Microbe 2020;27:502-6. [PMID: 32272075 DOI: 10.1016/j.chom.2020.03.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
51 Chou R. The High Burden of Sexually Transmitted Infections in Persons Initiating Preexposure Prophylaxis-Challenge or Opportunity? JAMA Netw Open 2019;2:e1917482. [PMID: 31825498 DOI: 10.1001/jamanetworkopen.2019.17482] [Cited by in F6Publishing: 1] [Reference Citation Analysis]